Clinical Trial Update: Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing work productivity and cognitive symptoms in patients with major depressive disorder treated with vortioxetine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Lundbeck Canada Inc. | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED